Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of cefepime and ceftazidime in combination with amikacin in the empirical treatment of high-risk patients with febrile neutropenia: a prospective, randomized, multicenter study.
Erman M, Akova M, Akan H, Korten V, Ferhanoğlu B, Köksal I, Cetinkaya Y, Uzun O, Unal S; Febrile Neutropenia Study Group of Turkey. Erman M, et al. Among authors: ferhanoglu b. Scand J Infect Dis. 2001;33(11):827-31. doi: 10.1080/00365540110076679. Scand J Infect Dis. 2001. PMID: 11760163 Clinical Trial.
A prospective randomized study of Chop versus Chop plus alpha-2B interferon in patients with intermediate and high grade non-Hodgkin's lymphoma: the International Oncology Study Group NHL1 Study.
Giles FJ, Shan J, Advani SH, Akan H, Aydogdu I, Aziz Z, Azim HA, Bapsy PP, Buyukkececi F, Chaimongkol B, Chen PM, Cheong SK, Ferhanoglu B, Hamza R, Khalid HM, Intragumtornchai T, Kim SW, Kim SY, Koc H, Kumar L, Kumar R, Lei KI, Lekhakula A, Muthalib A, Patel M, Poovalingam VP, Prayoonwiwat W, Rana F, Reksodiputro AH, Ruff P, Sagar TG, Schwarer AP, Song HS, Suh CW, Suharti C, Supindiman I, Tee GY, Thamprasit T, Villalon AH, Wickham NR, Wong JE, Yalcin A, Jootar S; International Oncology Study Group NHL1 Study. Giles FJ, et al. Among authors: ferhanoglu b. Leuk Lymphoma. 2000 Dec;40(1-2):95-103. doi: 10.3109/10428190009054885. Leuk Lymphoma. 2000. PMID: 11426633 Clinical Trial.
Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study.
Younes A, Brody J, Carpio C, Lopez-Guillermo A, Ben-Yehuda D, Ferhanoglu B, Nagler A, Ozcan M, Avivi I, Bosch F, Caballero Barrigón MD, Hellmann A, Kuss B, Ma DDF, Demirkan F, Yağci M, Horowitz NA, Marlton P, Cordoba R, Wrobel T, Buglio D, Streit M, Hodkinson BP, Schaffer M, Alvarez J, Ceulemans R, Balasubramanian S, de Jong J, Wang SS, Fourneau N, Jurczak W. Younes A, et al. Among authors: ferhanoglu b. Lancet Haematol. 2019 Feb;6(2):e67-e78. doi: 10.1016/S2352-3026(18)30217-5. Epub 2019 Jan 11. Lancet Haematol. 2019. PMID: 30642819 Clinical Trial.
Brentuximab vedotin consolidation therapy after autologous stem-cell transplantation in patients with high-risk Hodgkin lymphoma: Multicenter retrospective study.
Akay OM, Ozbalak M, Pehlivan M, Yildiz B, Uzay A, Yigenoglu TN, Elverdi T, Kaynar L, Ayyildiz O, Yonal Hindilerden I, Goksoy HS, Izmir Guner S, Gunes AK, Sonmez M, Kurt Yuksel M, Civriz Bozdag S, Ozkurt ZN, Toptas T, Dogu MH, Salim O, Saydam G, Yavasoglu I, Ayli M, Ozet G, Albayrak M, Birtas Atesoglu E, Toprak SK, Yildirim R, Mehtap O, Kalayoglu Besisik S, Nalcaci M, Altuntas F, Ferhanoglu B. Akay OM, et al. Among authors: ferhanoglu b. Hematol Oncol. 2021 Oct;39(4):498-505. doi: 10.1002/hon.2897. Epub 2021 Jun 25. Hematol Oncol. 2021. PMID: 34171130
Early Changes of Mannose-Binding Lectin, H-Ficolin, and Procalcitonin in Patients with Febrile Neutropenia: A Prospective Observational Study.
Işlak Mutcalı S, Saltoğlu N, Balkan İİ, Özaras R, Yemişen M, Tabak F, Mert A, Öztürk R, Öngören Ş, Başlar Z, Aydın Y, Ferhanoğlu B, Soysal T. Işlak Mutcalı S, et al. Among authors: ferhanoglu b. Turk J Haematol. 2016 Dec 1;33(4):304-310. doi: 10.4274/tjh.2014.0385. Epub 2015 Aug 6. Turk J Haematol. 2016. PMID: 26377840 Free PMC article.
Long-term results of brentuximab vedotin in relapsed and refractory Hodgkin lymphoma: multi-center real-life experience.
Özbalak M, Salihoğlu A, Soysal T, Karadoğan İ, Paydaş S, Özdemir E, Yıldız B, Karadurmuş N, Kaynar L, Yagci M, Özkocaman V, Topçuoğlu P, Özcan M, Birtaş E, Göker H, Ferhanoglu B. Özbalak M, et al. Among authors: ferhanoglu b. Ann Hematol. 2020 Feb;99(2):301-307. doi: 10.1007/s00277-019-03899-1. Epub 2019 Dec 17. Ann Hematol. 2020. PMID: 31844933
Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience.
Bekoz H, Ozbalak M, Karadurmus N, Paydas S, Turker A, Toptas T, Tuglular TF, Altuntas F, Cakar MK, Sonmez M, Gulbas Z, Demir N, Kaynar L, Yildirim R, Karadogan I, Arat M, Kapucu I, Aslan NA, Ozkocaman V, Turgut M, Yuksel MK, Ozcan M, Hacioglu SK, Barista I, Demirkaya M, Saydam G, Toprak SK, Yilmaz M, Demirkol O, Ferhanoglu B. Bekoz H, et al. Among authors: ferhanoglu b. Ann Hematol. 2020 Nov;99(11):2565-2576. doi: 10.1007/s00277-020-04077-4. Epub 2020 Jun 7. Ann Hematol. 2020. PMID: 32507911 Clinical Trial.
Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia: Retrospective Analysis of Real-Life Data.
Tombak A, Pepedil Tanrıkulu F, Durusoy SS, Dinçyürek HD, Kaya E, Ümit EG, Yavaşoğlu İ, Mehtap Ö, Deveci B, Özcan MA, Terzi H, Okay M, Sayınalp N, Yılmaz M, Okan V, Kızıklı A, Özcan Ö, Çetin G, Demircioğlu S, Aydoğdu İ, Saydam G, Davulcu EA, İlhan G, Uçar MA, Özet G, Akpınar S, Turgut B, Berber İ, Kurtoğlu E, Sönmez M, Batur DS, Yıldırım R, Özkocamaz V, Güneş AK, Sahip B, Ertop Ş, Akay OM, Baştürk A, Doğu MH, Akdeniz A, Ünal A, Seyhanlı A, Gürkan E, Çekdemir D, Ferhanoğlu B. Tombak A, et al. Among authors: ferhanoglu b. Turk J Haematol. 2021 Dec 7;38(4):273-285. doi: 10.4274/tjh.galenos.2021.2021.0007. Epub 2021 Aug 27. Turk J Haematol. 2021. PMID: 34448556 Free PMC article.
95 results